Toll-like receptor 2 ligands as adjuvants for human Th1 responses

被引:85
|
作者
Sieling, PA
Chung, W
Duong, BT
Godowski, PJ
Modlin, RL
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol & Immunol, Div Dermatol, Los Angeles, CA 90095 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 170卷 / 01期
关键词
D O I
10.4049/jimmunol.170.1.194
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bacterial lipopeptides (bLPs) are increasingly used as adjuvants to activate cell-mediated immune responses to foreign Ags. To explore mechanisms whereby bLPs adjuvant T cell responses, we stimulated human PBMCs with bLPs. We found that bLPs stimulate T cells to proliferate and produce IFN-gamma in an accessory cell-dependent manner and in the absence of exogenous protein Ags. The ability of bLPs to stimulate T cell proliferation was Toll-like receptor 2 dependent and required IL-12, interaction with costimulatory molecules, and MHC proteins. Our data suggest that bLPs adjuvant adaptive Th1 responses by enhancing Ag presentation of endogenous peptides.
引用
收藏
页码:194 / 200
页数:7
相关论文
共 50 条
  • [1] Orchestration of atopic dermatitis inflammation by Staphylococcus aureus: Toll-like receptor 2 ligands exaggerate dermatitis and Th1 responses
    Kaesler, S.
    Boettcher, Y.
    Chen, K.
    Guenova, E.
    Hein, U.
    Volz, T.
    Biederman, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S122 - S122
  • [2] Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation
    Tamayo, I.
    Irache, J. M.
    Mansilla, C.
    Ochoa-Reparaz, J.
    Lasarte, J. J.
    Gamazo, C.
    CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (09) : 1356 - 1362
  • [3] Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood
    De Wit, D
    Tonon, S
    Olislagers, V
    Goriely, S
    Boutriaux, M
    Goldman, M
    Willems, F
    JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) : 277 - 281
  • [4] Polymer conjugates of toll-like receptor ligands as vaccine adjuvants
    Lynn, G.
    Laga, R.
    Fisher, K.
    Seder, R.
    Seymour, L.
    HUMAN GENE THERAPY, 2011, 22 (10) : A70 - A70
  • [5] Toll-like receptor 2 is important for the TH1 response to cutaneous sensitization
    Jin, Haoli
    Kumar, Lalit
    Mathias, Clinton
    Zurakowski, David
    Oettgen, Hans
    Gorelik, Leonid
    Geha, Raif
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (04) : 875 - 882
  • [6] Toll-like Receptor 2 is Important for the Th1 Response to Cutaneous Sensitization
    Jin, Hooli
    Kumar, Lalit
    Mathias, Clinton
    Oettgen, Hans
    Geha, Raif
    Zurokowski, David
    CLINICAL IMMUNOLOGY, 2009, 131 : S111 - S111
  • [7] Toll-like receptor 2 ligands inhibit Th2 responses to mite allergen
    Taylor, RC
    Richmond, P
    Upham, JW
    TISSUE ANTIGENS, 2005, 66 (05): : 559 - 560
  • [8] Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen
    Taylor, Rebecca C.
    Richmond, Peter
    Upham, John W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (05) : 1148 - 1154
  • [9] Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy
    Johansen, P
    Senti, G
    Martinez Gomez, JM
    Storni, T
    Beust, BR
    Wüthrich, B
    Bot, A
    Kündig, TM
    CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (12): : 1591 - 1598
  • [10] Adjuvants containing natural and synthetic Toll-like receptor 4 ligands
    Ireton, Gregory C.
    Reed, Steven G.
    EXPERT REVIEW OF VACCINES, 2013, 12 (07) : 793 - 807